Recombinant BCG vaccines
- 20 July 2001
- Vol. 19 (30), 4089-4098
- https://doi.org/10.1016/s0264-410x(01)00155-4
Abstract
No abstract availableThis publication has 64 references indexed in Scilit:
- Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Secreting Merozoite Surface Protein 1 (MSP1) Induces Protection against Rodent Malaria Parasite Infection Depending on MSP1-stimulated Interferon γ and Parasite-specific AntibodiesThe Journal of Experimental Medicine, 1998
- Immunization of
BALB c International Journal for Parasitology, 1997 - A new series of mycobacterial expression vectors for the development of live recombinant vaccinesGene, 1996
- Stable expression and secretion of the B-cell epitope of rodent malaria from Mycobacterium bovis BCG and induction of long-lasting humoral response in mouseVaccine, 1996
- Immunity to Intracellular BacteriaAnnual Review of Immunology, 1993
- Use of gene probes based on the insertion sequence IS986 to differentiate between BCG vaccine strainsJournal of Applied Bacteriology, 1992
- Expression of heterologous genes in Mycobacterium bovis BCG: induction of a cellular response against HIV-1 Nef proteinGene, 1991
- Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccinesNature, 1991
- Immunotherapeutic effects of a vaccine based on a saprophytic cultivable mycobacterium, Mycobacterium w in multibacillary leprosy patientsVaccine, 1990
- THE EXPERIMENTAL DISEASE THAT FOLLOWS THE INJECTION OF HUMAN LEPROSY BACILLI INTO FOOT-PADS OF MICEThe Journal of Experimental Medicine, 1960